Laman UtamaDIVISLAB • NSE
add
Divi's Laboratories Ltd
Tutup sebelumnya
₹6,015.50
Julat hari
₹6,004.00 - ₹6,083.50
Julat tahun
₹4,955.00 - ₹7,071.50
Permodalan pasaran
1.60T INR
Bilangan Purata
418.54K
Nisbah P/E
69.30
Hasil dividen
0.50%
Pertukaran utama
NSE
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 24.10B | 13.79% |
Perbelanjaan pengendalian | 8.37B | 13.26% |
Pendapatan bersih | 5.45B | 26.74% |
Margin untung bersih | 22.61 | 11.38% |
Pendapatan bagi setiap syer | 20.49 | 26.48% |
EBITDA | 7.16B | 15.66% |
Kadar cukai berkesan | 25.65% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 35.27B | -4.62% |
Jumlah aset | — | — |
Jumlah liabiliti | — | — |
Jumlah ekuiti | 149.69B | — |
Syer tertunggak | 265.98J | — |
Harga kepada buku | 10.67 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 10.30% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 5.45B | 26.74% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
Diasaskan
12 Okt 1990
Tapak web
Pekerja
10,542
